1. Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/alpha-interferon;Alpaugh;Med. Oncol.,1998
2. Phase I evaluation of a combination of monoclonal antibody R24 and interleukin 2 in patients with metastatic melanoma;Bajorin;Cancer Res.,1990
3. Treatment with high dose mouse monoclonal (anti-GD3) antibody R24 in patients with metastatic melanoma;Bajorin;Melanoma Res.,1992
4. Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial;Bergman;Clin. Cancer Res.,2003
5. Cell-mediated responses in dogs with spontaneous neoplasms. I. Detection of cell-mediated cytotoxicity by the chromium-51 release assay;Betton;J. Natl. Cancer Inst.,1978